Effects of 7-methylxanthine on form-deprivation myopia in pigmented rabbits

Hao-Hui Nie1, Li-Jun Huo, Xiao Yang

  • 1State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, SunYat-sen University, Guangzhou 510060, Guangdong Province, China.

Abstract

Insights

7-methylxanthine (7-MX) significantly reduced form-deprivation myopia (FDM) in rabbits by altering posterior scleral collagen. This suggests 7-MX may prevent myopia progression through scleral remodeling.

Area of Science:

  • Ophthalmology
  • Pharmacology
  • Biochemistry

Background:

  • Myopia, a prevalent vision disorder, is often linked to axial elongation of the eye.
  • Form-deprivation myopia (FDM) is a common experimental model used to study myopia development.
  • The sclera plays a critical role in regulating eye growth and refractive development.

Purpose of the Study:

  • To investigate the potential of 7-methylxanthine (7-MX) to prevent or mitigate form-deprivation myopia (FDM) in a rabbit model.
  • To examine the effect of 7-MX on the structural properties of the posterior sclera in the context of FDM.

Main Methods:

  • Form-deprivation myopia was induced in pigmented rabbits by monocular eyelid suture for 30 days.
  • Rabbits were orally administered either 7-MX or a vehicle control.
  • Ocular refraction, axial length, and posterior scleral collagen fibril diameters were measured.

Main Results:

  • Vehicle control rabbits developed significant myopia (-1.10D) and axial elongation (0.51mm).
  • 7-MX treated rabbits showed significantly reduced myopia (-0.21D) and axial elongation (0.07mm).
  • 7-MX treatment led to increased collagen fibril diameters in the posterior sclera.

Conclusions:

  • 7-methylxanthine (7-MX) demonstrates a protective effect against form-deprivation myopia in rabbits.
  • The mechanism appears to involve the remodeling of posterior scleral collagen structure.
  • 7-MX holds potential as a therapeutic agent for myopia prevention.

Related Concept Videos